John Maraganore
Signal active
CEO
Bio
Chief Executive Officer & Director at Alnylam Pharmaceuticals.
Location
Boston, Massachusetts, United States, North America
Social
Primary Organization
Alnylam Pharmaceuticals
Founded
2002
Employees
1001-5000
Industry
Biotechnology, Health Care, Pharmaceutical, Medical, Therapeutics
Jobs history
2
Prokidney
Board Member
Invalid date - Current
Alnylam Pharmaceuticals
Leadership Transition
2021 - Current
Board and Advisor Roles
0
N/A
Invest in regions
Profile Resume
John Maraganore is the CEO at Alnylam Pharmaceuticals, based in United States, North America. With a background in Biotechnology, John Maraganore has a rich history of leadership and innovation. John Maraganore studied Ph.D Biochemistry and Molecular Biology @ University of Chicago. Explore their detailed professional journey, key connections, and contributions to the industry on our platform.
Investment portfolio
John Maraganore has made 4 investments. Their Latest investment was Venture Round - Terray Therapeutics on Nov 09, 2023
Number of investment
4
Number of exits
1
Personal investment
4
| Annouced Date | Organization Name | Funding Round | Money Raised |
|---|---|---|---|
| Apr 21, 2022 | Xinvento | Seed Round - Xinvento | 0 |
| Nov 10, 2022 | Lipidio Pharmaceuticals | Series A - Lipidio Pharmaceuticals | 20.0M |
| Mar 01, 2023 | Thymmune Therapeutics | Seed Round - Thymmune Therapeutics | 7.0M |
| Nov 09, 2023 | Terray Therapeutics | Venture Round - Terray Therapeutics | 0 |
Partner investment
1
| Annouced Date | Organization Name | Funding Round | Investor Name | Money Raised |
|---|---|---|---|---|
| Jul 07, 2008 | Agios Pharmaceuticals | Series A - Agios Pharmaceuticals | Third Rock Ventures | 33.0M |
Agios Pharmaceuticals
Third Rock Ventures
Invest in industries
Recent Activity
There is no recent news or activity for this profile.